Professor Schmid is an internationally renowned breast cancer oncologist. He is the clinical director of the Breast Cancer Centre at St. Bartholomew’s Hospital in London, and Chair in Cancer Medicine at Barts Cancer Institute, Queen Mary University London.

Professor Peter Schmid’s work is devoted to incorporating novel therapies based on an understanding of the biology of cancer with excellent quality of care into the treatment of women with breast cancer. He has an interest in breast cancer from diagnosis throughout treatment to optimal recovery, and also has a particular interest in triple-negative breast cancer, young women with breast cancer, pregnancy-associated breast cancer, and fertility-related issues. Professor Schmid is committed to patient-centered, holistic care, tailoring treatments for individual patients using biology, personal preference, and constant review of outcomes of care. He works in the context of a multidisciplinary team with breast care nurse support for patients. Professor Schmid has a strong interest in patient-doctor communication and ran a training program for oncologists and oncology nurses for many years. Professor Schmid’s research is dedicated to improving the care of women with breast cancer by developing more effective and less toxic treatments.

It is important that HCA be transparent about our relationship with those doctors who provide us with clinical guidance on delivering the best possible care to patients and operating our hospitals safely and efficiently. We set out here some of the ways in which we work together and the amount we pay this doctor for such services.